A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers

NCT04400123 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

DRUG: Famitinib malate

Sponsor

Jiangsu HengRui Medicine Co., Ltd.